Key Takeaways Missing a single GLP-1 dose does not stop the medication from working or cause immediate weight regain
Using next-generation RNA-seq sequencing technology, they confirmed that GHK-Cu modulates the expression of 4,231 genes , of which 2,861 are upregulated and 1,370 are downregulated
The decision to initiate pharmacotherapy should involve shared decision-making, considering individual patient values, preferences, treatment goals, and cost considerations, as these medications can be expensive and may face insurance coverage limitations
Despite significant ablation advancements, AFibs recurrence risk is ~30% at one year and rises over time, likely due to cardiometabolic factors like obesity
Whats coming next: retatrutide No comparison of this drug class would be complete without mentioning retatrutide a triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously